Trellus Health PLC (GB:TRLS) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Trellus Health PLC has made significant strides in its chronic condition management programs, particularly for IBD, with the signing of major B2B2C agreements and a promising partnership with a large US health plan. The company concluded its pilot programs successfully and entered into licensing agreements with pharmaceutical companies, illustrating the value of its proprietary methodology. Despite a net cash decrease, Trellus Health’s careful cash management has extended its operational runway into mid-2025, with a focus on continued commercial growth and improved health outcomes.
For further insights into GB:TRLS stock, check out TipRanks’ Stock Analysis page.